Natera (NASDAQ:NTRA – Get Rating) had its price objective increased by Credit Suisse Group from $65.00 to $70.00 in a research report released on Wednesday morning, The Fly reports. NTRA has been the subject of several other reports. Raymond James lifted their price target on Natera from $58.00 to $68.00 and gave the company an […]
FORA Capital LLC bought a new position in Natera, Inc. (NASDAQ:NTRA – Get Rating) in the fourth quarter, HoldingsChannel.com reports. The fund bought 8,296 shares of the medical research company’s stock, valued at approximately $333,000. A number of other large investors have also added to or reduced their stakes in NTRA. Belpointe Asset Management LLC […]
Natera (NASDAQ:NTRA – Get Rating) had its price objective hoisted by Credit Suisse Group from $65.00 to $70.00 in a research note released on Wednesday morning, The Fly reports. A number of other equities analysts have also recently commented on the stock. UBS Group started coverage on shares of Natera in a research note on […]
Natera (NASDAQ:NTRA – Get Rating) posted its quarterly earnings results on Tuesday. The medical research company reported ($1.23) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.18) by ($0.05), Briefing.com reports. Natera had a negative net margin of 66.79% and a negative return on equity of 106.67%. The business had revenue […]
Natera (NASDAQ:NTRA – Get Rating) issued its earnings results on Tuesday. The medical research company reported ($1.23) EPS for the quarter, missing the consensus estimate of ($1.18) by ($0.05), Briefing.com reports. The company had revenue of $241.76 million for the quarter, compared to analysts’ expectations of $227.43 million. Natera had a negative return on equity […]